BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors

NCT01957735 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Cancer
Cancer
Solid Tumor

Interventions

DRUG: BP31510 monotherapy
DRUG: BP31510 in combination with chemotherapy

Sponsor

BPGbio